Inflammation, obesity, and fatty acid metabolism: Influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome

Applied Physiology, Nutrition and Metabolism

Volumn 32, Issue 6, 2007, Pages 1008-1024

  Robinson, Lindsay E ^a   Buchholz, Andrea C ^a   Mazurak, Vera C ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diet; Fatty acids; Inflammation; Metabolic syndrome; Metabolism; n 3 PUFA; Obesity

Indexed keywords

FATTY ACID; OMEGA 3 FATTY ACID;

DIET; DIET THERAPY; DYSLIPIDEMIA; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; METABOLISM; OBESITY; PHYSIOLOGY; REVIEW;

ADIPOSITY; DIET; DYSLIPIDEMIAS; FATTY ACIDS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; OBESITY;

EID: 39049131173     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H07-087     Document Type: Review

References (143)

1. Abbey, M., Clifton, P., Kestin, M., and Belling, B. 1990. Effect of fish oil on lipoprotein, lecithin:cholesterol acyltransferase and lipid transfer protein activity in humans. Arteriosclerosis, 10: 85-94.
2. Accinni, R., Rosina, M., Bamonti, F., Della Noce, C., Tonini, A., Bernacchi, F., et al. 2006. Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects. Nutr. Metab. Cardiovasc. Dis. 16: 121-127. doi:10.1016/j.numecd.2005.05.006.
3. Ajuwon, K.M., and Spurlock, M.E. 2005. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFα expression in 3T3-L1 adipocytes. J. Nutr. 135: 1841-1846.
4. Alberti, K.G.M.M., Zimmet, P., and Shaw, J., and IDF Epidemiology Task Force Consensus Group. 2005. The metabolic syndrome - a new worldwide definition. Lancet, 366: 1059-1062. doi:10.1016/S0140-6736(05)67402-8.
5. Ardern, C.I., and Janssen, I. 2007. Metabolic syndrome and its association with morbidity and mortality. Appl. Physiol. Nutr. Metab. 32: 33-45. doi:10.1139/H06-099.
6. Bastard, J.P., Jardel, C., Bruckert, E., Blondy, P., Capeau, J., Laville, M., et al. 2000. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J. Clin. Endocrinol. Metab. 85: 3338-3342. doi:10.1210/jc.85.9.3338.
7. Bemelmans, W.J., Lefrandt, J.D., Feskens, E.J., van Haelst, P.L., Broer, J., Meyboom-de Jong, B., et al. 2004. Increased α-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur. J. Clin. Nutr. 58: 1083-1089. doi:10.1038/sj.ejcn.1601938.
8. Bjerregaard, P., Pedersen, H.S., and Mulvad, G. 2000. The associations of a marine diet with plasma lipids, blood glucose, blood pressure and obesity among the Inuit in Greenland. Eur. J. Clin. Nutr. 54: 732-737. doi:10.1038/sj.ejcn.1601088.
9. Blok, W.L., Deslypere, J.P., Demacker, P.N., van der Ven-Jongekrijg, J., Hectors, M.P., van der Meer, J.W., and Katan, M.B. 1997. Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur. J. Clin. Invest. 27: 1003-1008. doi:10.1046/j.1365-2362. 1997.2240775.x.
10. Blackburn, P., Cote, M., Lamarche, B., Couillard, C., Pascot, A., Tremblay, A., et al. 2003. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism, 52: 1379-1386. doi:10.1016/S0026-0495(03)00315-9.
11. Bolton-Smith, C., Woodward, M., and Tavendale, R. 1997. Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet. Eur. J. Clin. Nutr. 51: 619-624. doi:10.1038/sj.ejcn.1600455.
12. Browning, L.M. 2003. n-3 Polyunsaturated fatty acids, inflammation and obesity-related disease. Proc. Nutr. Soc. 62: 447-453. doi:10.1079/PNS2003252.
13. Browning, L.M., Krebs, J.D., Moore, C.S., Mishra, G.D., O'Connell, M.A., and Jebb, S.A. 2007. The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes. Metab. 9: 70-80. doi:10.1111/j.1463-1326.2006.00576.x.
14. Bruun, J.M., Verdich, C., Toubro, S., Astrup, A., and Richelsen, B. 2003. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-α. Effect of weight loss in obese men. Eur. J. Endocrinol. 148: 535-542. doi:10.1530/eje.0.1480535.
15. Buckley, R., Shwing, B., Turner, R., Yaqoob, P., and Minihane, A.M. 2004. Circulating triacylglyceride and apoprotein E levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. Br. J. Nutr. 92: 477-483. doi:10.1079/BJN20041235.
16. Burdge, G.C., and Calder, P.C. 2005. Plasma cytokine response during the postprandial period: a potential causal process in vascular disease? Br. J. Nutr. 93: 3-9. doi:10.1079/BJN20041282.
17. Burdge, G.C., and Wootton, S.A. 2002. Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br. J. Nutr. 88: 411-420.
18. Burdge, G.C., Jones, A.E., and Wootton, S.A. 2002. Eicosapentaenoic and docosapentaenoic acids are the principal products of α-linolenic acid metabolism in young men. Br. J. Nutr. 88: 355-363.
19. Calder, P.C. 2006a. n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am. J. Clin. Nutr. 83(6 Suppl.): 1505S-1519S.
20. Calder, P.C. 2006b. Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot. Essent. Fatty Acids, 75: 197-202. doi:10.1016/j.plefa.2006.05.012.
21. Cantwell, M.M., Flynn, M.A.T., and Gibney, M.J. 2006. Acute postprandial effect of hydrogenated fish oil, palm oil and lard on plasma cholesterol, triacyglycerol and non-esterified fatty acid metabolism in normocholesterolemic males. Br. J. Nutr. 95: 787-794. doi:10.1079/BJN20051723.
22. Carmena, R., Duriez, P., and Fruchart, J.C. 2004. Atherogenic lipoprotein particles in atherosclerosis. Circulation, 109: III2-III7.
23. Carpentier, Y.A., Portois, L., and Malaisse, W.J. 2006. n-3 Fatty acids and the metabolic syndrome. Am. J. Clin. Nutr. 83: 1499S-1504S.
24. Chambrier, C., Bastard, J.P., Rieusset, J., Chevillotte, E., Bonnefont-Rousselot, D., Therond, P., et al. 2002. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma. Obes. Res. 10: 518-525.
25. Chan, D.C., Watts, G.F., Barrett, H.R., Beilin, L.J., and Mori, T.A. 2002. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clin. Chem. 48: 877-883.
26. Chandran, M., Phillips, S.A., Ciaraldi, T., and Henry, R.R. 2003. Adiponectin: more than just another fat cell hormone? Diabetes Care, 26: 2442-2450. doi:10.2337/diacare.26.8.2442.
27. Chinetti, G., Fruchart, J.C., and Staels, B. 2000. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49: 497-505. doi:10.1007/s000110050622.
28. Ciubotaru, I., Lee, Y.S., and Wander, R.C. 2003. Dietary fish oil decreases C-reactive protein, interleukin-6, and triacylglycerol to HDL-cholesterol ratio in postmenopausal women on HRT. J. Nutr. Biochem. 14: 513-521.
29. Clarke, S.D. 2000. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br. J. Nutr. 83: S59-S66.
30. Couet, C., Delarue, J., Ritz, P., Antoine, J.-M., and Lamisse, F. 1997. Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int. J. Obes. 21: 637-643. doi:10.1038/sj.ijo.0800451.
31. Corpeleijn, E., Saris, W.H., Jansen, E.H., Roekaerts, P.M., Feskens, E.J., and Blaak, E.E. 2005. Postprandial interleukin-6 release from skeletal muscle in men with impaired glucose tolerance can be reduced by weight loss. J. Clin. Endocrinol. Metab. 90: 5819-5824. doi:10.1210/jc.2005-0668.
32. Das, U.N. 2001. Nutritional factors in the pathobiology of human essential hypertension. Nutrition, 17: 337-346. doi:10.1016/S0899- 9007(00)00586-4.
33. Dekker, M.J., Lee, S., Hudson, R., Kilpatrick, K., Graham, T.E., Ross, R., and Robinson, L.E. 2007. An exercise intervention without weight loss decreases circulating interleukin-6 in lean and obese men with and without type 2 diabetes mellitus. Metabolism, 56: 332-338. doi:10.1016/j.metabol.2006. 10.015.
34. DeLany, J.P., Windhauser, M.M., Champagne, C.M., and Bray, G.A. 2000. Differential oxidation of individual fatty acids in humans. Am. J. Clin. Nutr. 72: 905-911.
35. de Lorgeril, M., Salen, P., Martin, J.L., Monjaud, I., Delaye, J., and Mamelle, N. 1999. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation, 99: 779-785.
36. Despres, J.P. 1993. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition, 9: 452-459.
37. Desroches, S., and Lamarche, B. 2007. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl. Physiol. Nutr. Metab. 32: 23-32. doi:10.1139/H06-095.
38. Devchand, P.R., Ijpenberg, A., Devesvergne, B., and Wahli, H. 1999. PPARs: nuclear receptors for fatty acids, eicosanoids, and xenobiotics. Adv. Exp. Med. Biol. 469: 231-236.
39. Djousse, L., Arnett, D.K., Pankow, J.S., Hopkins, P.N., Province, M.A., and Ellison, R.C. 2005. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension, 45: 368-373. doi:10.1161/01.HYP.0000154679.41568.e6.
40. Endres, S., Ghorbani, R., Kelley, V.E., Georgilis, K., Lonnemann, G., van der Meer, J.W., et al. 1989. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N. Engl. J. Med. 320: 265-271.
41. English, P.J., Coughlin, S.R., Hayden, K., Malik, I.A., and Wilding, J.P. 2003. Plasma adiponectin increases postprandially in obese, but not in lean, subjects. Obes. Res. 11: 839-844.
42. Esposito, K., Nappo, F., Giugliano, F., Giugliano, G., Marfella, R., and Giugliano, D. 2003a. Effect of dietary antioxidants on postprandial endothelial dysfunction induced by a high-fat meal in healthy subjects. Am. J. Clin. Nutr. 77: 139-143.
43. Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., and Giugliano, D. 2003b. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA, 289: 1799-1804. doi:10.1001/jama.289.14.1799.
44. Esposito, K., Nappo, F., Giugliano, F., Di Palo, C., Ciotola, M., Barbieri, M., et al. 2003c. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr. 78: 1135-1140.
45. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285: 2486-2497. doi:10.1001/jama.285.19.2486.
46. Fernandez-Real, J.M., Broch, M., Vendrell, J., and Ricart, W. 2003. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care, 26: 1362-1368. doi:10.2337/diacare.26.5.1362.
47. Ferrucci, L., Cherubini, A., Bandinelli, S., Bartali, B., Corsi, A., Lauretani, F., et al. 2006. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 91: 439-446.
48. Festa, A., D'Agostino, R., Jr., Tracy, R.P., Karter, A.J., Saad, M.F., and Haffner, S.M. 2002. Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes, 51: 1131-1137. doi:10.2337/diabetes.51.4.1131.
49. Finnegan, Y.E., Minihane, A.M., Leigh-Firbank, E.C., Kew, S., Meijer, G.W., Muggli, R., et al. 2003. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am. J. Clin. Nutr. 77: 783-795.
50. Fontani, G., Corradeschi, F., Felici, A., Alfatti, F., Bugarini, R., Fiaschi, A.I., et al. 2005. Blood profiles, body fat and mood state in healthy subjects on different diets supplemented with omega-3 polyunsaturated fatty acids. Eur. J. Clin. Invest. 35: 499-507. doi:10.1111/j.1365-2362.2005. 01540.x.
51. Freeman, D.J., Norrie, J., Caslake, M.J., Gaw, A., Ford, I., Lowe, G.D., et al. 2002. C-reactive protein is an independent predictor for risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51: 1596-1600. doi:10.2337/diabetes.51.5.1596.
52. Fried, S.K., Bunkin, D.A., and Greenberg, A.S. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoids. J. Clin. Endocrinol. Metab. 83: 847-850. doi:10.1210/jc.83.3.847.
53. Fujioka, S., Hamazaki, K., Itomura, M., Huan, M., Nishizawa, H., Sawazaki, S., et al. 2006. The effects of eicosapentaenoic acid-fortified food on inflammatory markers in healthy subjects - a randomized, placebo-controlled, double-blind study. J. Nutr. Sci. Vitaminol. (Tokyo), 52: 261-265.
54. Garaulet, M., Pérez-Llamas, F., Pérez-Ayala, M., Martínez, P., de Medina, F., Tebar, F.J., and Zamora, S. 2001. Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. Am. J. Clin. Nutr. 74: 585-591.
55. Geelen, A., Brouwer, I.A., Schouten, E.G., Kluft, C., Katan, M.B., and Zock, P.L. 2004. Intake of n-3 fatty acids from fish does not lower serum concentrations of C-reactive protein in healthy subjects. Eur. J. Clin. Nutr. 58: 1440-1442. doi:10.1038/sj.ejcn.1601986.
56. Geppert, J., Kraft, V., Demmelmair, H., and Koletzko, B. 2006. Microalgal docosahexaenoic acid decreases plasma triacylglycerol in normolipidemia vegetarians: a randomised trial. Br. J. Nutr. 95: 779-786. doi:10.1079/BJN20051720.
57. Ghosh, A. 2006. Comparison of anthropometric, metabolic and dietary fatty acids profiles in lean and obese dyslipidaemic Asian Indian male subjects. Eur. J. Clin. Nutr. 61: 412-419.
58. Giugliano, D., Ceriello, A., and Esposito, K. 2006. The effects of diet on inflammation: emphasis on the metabolic syndrome. J. Am. Coll. Cardiol. 48: 677-685. doi:10.1016/j.jacc.2006.03.052.
59. Grimble, R.F. 1998. Dietary lipids and the inflammatory response. Proc. Nutr. Soc. 57: 535-542. doi:10.1079/PNS19980078.
60. Grundt, H., Nilsen, D.W., Hetland, O., Aarsland, T., Baksaas, I., Grande, T., and Woie, L. 1995. Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia. J. Intern. Med. 237: 249-259.
61. Han, S.N., Leka, L.S., Lichtenstein, A.H., Ausman, L.M., Schaefer, E.J., and Meydani, S.N. 2002. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J. Lipid Res. 43: 445-452.
62. Harbige, L.S. 2003. Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids, 38: 323-341. doi:10.1007/s11745-003-1067-z.
63. Harris, W.S. 1989. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J. Lipid Res. 30: 785-807.
64. Harris, W.S. 1997. n-3 Fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65(Suppl. 5): 1645S-1654S.
65. Harris, W.S., and Bulchandani, D. 2006. Why do omega-3 fatty acids lower serum triglycerides? Curr. Opin. Lipidol. 17: 387-393.
66. Heine, R.J., and Dekker, J.M. 2002. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia, 45: 461-475. doi:10.1007/s00125-001-0726-0.
67. Hill, J.O., Peters, J.C., Lin, D., Yakubu, F., Greene, H., and Swift, L. 1993. Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int. J. Obes. Relat. Metab. Disord. 17: 223-226.
68. Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., et al. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20: 1595-1599.
69. Houseknecht, K.L., Cole, B.M., and Steele, P.J. 2002. Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review. Domest. Anim. Endocrinol. 22: 1-23. doi:10.1016/S0739-7240(01)00117-5.
70. Huang, X.-F., Xin, X., McLennan, P., and Storlien, L. 2004. Role of fat amount and type in ameliorating diet-induced obesity: insights at the level of hypothalamic arcuate nucleus leptin receptor, neuropeptide Y and pro-opiomelanocortin mRNA expression. Diabetes Obes. Metab. 6: 35-44. doi:10.1111/j.1463-1326.2004.00312.x.
71. Hutley, L., and Prins, J.B. 2005. Fat as an endocrine organ: relationship to the metabolic syndrome. Am. J. Med. Sci. 330: 280-289. doi:10.1097/00000441-200512000-00005.
72. James, M.J., Gibson, R.A., and Cleland, L.G. 2000. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am. J. Clin. Nutr. 71: 343S-348S.
73. Jellema, A., Plat, J., and Mensink, R.P. 2004. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur. J. Clin. Invest. 34: 766-773. doi:10.1111/j.1365-2362.2004.01414.x.
74. Jump, D.B., Thelen, A., Ren, B., and Mater, M. 1999. Multiple mechanisms for polyunsaturated fatty acid regulation of hepatic gene transcription. Prostaglandins, Leukot. Essent. Fatty Acids, 60: 345-349. doi:10.1016/S0952-3278(99)80010-6.
75. Klein-Platat, C., Drai, J., Oujaa, M., Schlienger, J.L., and Simon, C. 2005. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am. J. Clin. Nutr. 82: 1178-1184.
76. Kolovou, G.D., Anagnostopoulou, K.K., Pavlidis, A.N., Salpea, K.D., Iraklianou, S.A., Tsarpalis, K., et al. 2005a. Postprandial lipemia in men with metabolic syndrome, hypertensives and healthy subjects. Lipids Health Dis. 4: 21. doi:10.1186/1476-511X-4-21.
77. Kolovou, G.D., Anagnostopoulou, K.K., Daskalopoulou, S.S., Mikhailidis, D.P., and Cokkinos, D.V. 2005b. Clinical relevance of postprandial lipaemia. Curr. Med. Chem. 12: 1931-1945. doi:10.2174/0929867054546609.
78. Krebs, J.D., Browning, L.M., McLean, N.K., Rothwell, J.L., Mishra, J.D., Moore, C.S., and Jebb, S.A. 2006. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinemic women. Int. J. Obes. 30: 1535-1544. doi:10.1038/sj.ijo.0803309.
79. Kriketos, A.D., Robertson, R.M., Sharp, T.A., Drougas, H., Reed, G.W., Storlien, L.H., and Hill, J.O. 2001. Role of weight loss and polyunsaturated fatty acids in improving metabolic fitness in moderately obese, moderately hypertensive subjects. J. Hypertens. 19: 1745-1754. doi:10.1097/00004872- 200110000-00007.
80. Kris-Etherton, P.M., Harris, W.S., and Appel, L.J. 2002. American Heart Association. Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 106: 2747-2757. doi:10.1161/01.CIR.0000038493.65177.94.
81. Kukkonen-Harjula, K.T., Borg, P.T., Nenonen, A.M., and Fogelholm, M.G. 2005. Effects of a weight maintenance program with or without exercise on the metabolic syndrome: a randomized trial in obese men. Prev. Med. 41: 784-790.
82. Kunesova, M., Braunerova, R., Hlavaty, P., Tvrzicka, E., Stankova, B., Skrha, J., et al. 2006. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol. Res. 55: 63-72.
83. Lau, D.C., Dillon, B., Yan, H., Szmitko, P.E., and Verma, S. 2005. Adipokines: molecular links between obesity and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 288: H2031-H2041. doi:10.1152/ajpheart.01058.2004.
84. Linnemann, B., Voigt, W., Nobel, W., and Janka, H.U. 2006. C-reactive protein is a strong independent predictor of death in type 2 diabetes: association with multiple facets of the metabolic syndrome. Exp. Clin. Endocrinol. Diabetes, 114: 127-134. doi:10.1055/s-2006-924012.
85. Lofgren, I.E., Herron, K.L., West, K.L., Zern, T.L., Brownbill, R.A., Ilich, J.Z., et al. 2005. Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women. J. Am. Coll. Nutr. 24: 486-493.
86. Lopez-Garcia, E., Schulze, M.B., Fung, T.T., Meigs, J.B., Rifai, N., Manson, J.E., and Hu, F.B. 2004. Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am. J. Clin. Nutr. 80: 1029-1035.
87. Lovegrove, J.A., Brooks, C.N., Murphy, M.C., Gould, B.J., and Williams, C.M. 1997. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake. Br. J. Nutr. 78: 223-236. doi:10.1079/BJN19970142.
88. Luo, J., Rizkalla, S.W., Vidal, H., Oppert, J.M., Colas, C., Boussairi, A., et al. 1998. Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Diabetes Care, 21: 717-724. doi:10.2337/diacare. 21.5.717.
89. Madsen, T., Christensen, J.H., Blom, M., and Schmidt, E.B. 2003. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose-response study. Br. J. Nutr. 89: 517-522. doi:10.1079/BJN2002815.
90. Manning, P.J., Sutherland, W.H., Hendry, G., DeJong, S.A., McGrath, M., and Williams, S.M. 2004. Changes in circulating postprandial proinflammatory cytokine concentrations in diet-controlled type 2 diabetes and the effect of ingested fat. Diabetes Care, 27: 2509-2511. doi:10.2337/diacare.27.10. 2509.
91. Mohamed-Ali, V., Goodrick, S., Rawesh, A., Katz, D.R., Miles, J.M., Yudkin, J.S., et al. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J. Clin. Endocrinol. Metab. 82: 4196-4200. doi:10.1210/jc.82.12.4196.
92. Monzillo, L.U., Hamdy, O., Horton, E.S., Ledbury, S., Mullooly, C., Jarema, C., et al. 2003. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res. 11: 1048-1054.
93. Moore, C.S., Bryant, S.P., Mishra, G.D., Krebs, J.D., Browning, L.M., Miller, G.J., and Jebb, S.A.. 2006. Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women. Nutrition, 22: 1012-1024. doi:10.1016/j.nut.2006.07.005.
94. Mori, T.A., Bao, D.Q., Burke, V., Puddey, I.B., Watts, G.F., and Beilin, L.J. 1999. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am. J. Clin. Nutr. 70: 817-825.
95. Mori, T.A., Burke, V., Puddey, I.B., Watts, G.F., O'Neal, D.N., Best, J.D., and Beilin, L.J. 2000. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am. J. Clin. Nutr. 71: 1085-1094.
96. Mori, T.A., Woodman, R.J., Burke, V., Puddey, I.B., Croft, K.D., and Beilin, L.J. 2003. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic. Biol. Med. 35: 772-781. doi:10.1016/S0891-5849(03)00407-6.
97. Mozaffarian, D., Pischon, T., Hankinson, S.E., Rifai, N., Joshipura, K., Willett, W.C., and Rimm, E.B. 2004. Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 79: 606-612.
98. Murphy, K.J., Galvin, K., Kiely, M., Morrissey, P.A., Mann, N.J., and Sinclair, A.J. 2006. Low dose supplementation with two different marine oils does not reduce pro-inflammatory eicosanoids and cytokines in vivo. Asia Pac. J. Clin. Nutr. 15: 418-424.
99. Nappo, F., Esposito, K., Cioffi, M., Giugliano, G., Molinari, A.M., Paolisso, G., et al. 2002. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J. Am. Coll. Cardiol. 39: 1145-1150. doi:10.1016/S0735-1097(02)01741-2.
100. Nestel, P.J. 2000. Fish oil and cardiovascular disease: lipids and arterial function. Am. J. Clin. Nutr. 71: 228S-231S.
101. Nettleton, J.A., and Katz, R. 2005. n-3 Long chain polyunsaturated fatty acids in type 2 diabetes: areview. J. Am. Diet. Assoc. 105: 428-440. doi:10.1016/j.jada.2004.11.029.
102. Newman, R.E., Bryden, W.L., Fleck, E., Ashes, J.R., Buttemer, W.A., Storlien, L.H., and Downing, J.A. 2002. Dietary n-3 and n-6 fatty acids alter avian metabolism: metabolism and abdominal fat deposition. Br. J. Nutr. 88: 11-18.
103. Novak, T.E., Babcock, T.A., Jho, D.H., Helton, W.S., and Espat, N.J. 2003. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-α transcription. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L84-L89.
104. Orban, Z., Remaley, A.T., Sampson, M., Trajanoski, Z., and Chrousos, G.P. 1999. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. J. Clin. Endocrinol. Metab. 84: 2126-2133. doi:10.1210/jc.84.6.2126.
105. Paglialunga, S., and Cianflone, K. 2007. Regulation of postprandial lipemia: an update on current trends. Appl. Physiol. Nutr. Metab. 32: 61-75. doi:10.1139/H06-100.
106. Paschos, G.K., Rallidis, L.S., Liakos, G.K., Panagiotakos, D., Anastasiadis, G., Votteas, V., and Zampelas, A. 2004. Background diet influences the anti-inflammatory effect of α-linolenic acid in dyslipidaemic subjects. Br. J. Nutr. 92: 649-655. doi:10.1079/BJN20041230.
107. Patch, C.S., Tapsell, L.C., Mori, T.A., Meyer, B.J., Murphy, K.J., Mansour, J., et al. 2005. The use of novel foods enriched with long-chain n-3 fatty acids to increase dietary intake: a comparison of methodologies assessing nutrient intake. J. Am. Diet. Assoc. 105: 1918-1926.
108. Pickup, J.C., Mattock, M.B., Chusney, G.D., and Burt, D. 1997. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 40: 1286-1292. doi:10.1007/s001250050822.
109. Pischon, T., Hankinson, S.E., Hotamisligil, G.S., Rifai, N., Willett, W.C., and Rimm, E.B. 2003. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation, 108: 155-160. doi:10.1161/01.CIR.0000079224.46084.C2.
110. Poppitt, S.D. 2005. Postprandial lipaemia, haemostasis, inflammatory response and other emerging risk factors for cardiovascular disease: the influence of fatty meals. Curr. Nutr. Food Sci. 1: 23-34.
111. Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., and Ridker, P.M. 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 286: 327-334. doi:10.1001/jama.286.3.327.
112. Rallidis, L.S., Paschos, G., Liakos, G.K., Velissaridou, A.H., Anastasiadis, G., and Zampelas, A. 2003. Dietary α-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis, 167: 237-242. doi:10.1016/S0021-9150(02) 00427-6.
113. Rexrode, K.M., Pradhan, A., Manson, J.E., Buring, J.E., and Ridker, P.M. 2003. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann. Epidemiol. 13: 674-682. doi:10.1016/S1047-2797(03)00053-X.
114. Riccardi, G., Giacco, R., and Rivellese, A.A. 2004. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin. Nutr. 23: 447-456. doi:10.1016/j.clnu.2004.02.006.
115. Ridker, P.M., Hennekens, C.H., Buring, J.E., and Rifai, N. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342: 836-843. doi:10.1056/NEJM200003233421202.
116. Ridker, P.M., Rifai, N., Rose, L., Buring, J.E., and Cook, N.R. 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347: 1557-1565. doi:10.1056/NEJMoa021993.
117. Robinson, L.E., and Graham, T.E. 2004. Metabolic syndrome, a cardiovascular disease risk factor: role of adipocytokines and impact of diet and physical activity. Can. J. Appl. Physiol. 29: 808-829.
118. Sampath, H., and Ntambi, J.M. 2005. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 25: 317-340. doi:10.1146/annurev.nutr.25.051804.101917.
119. Sánchez-Villegas, A., Bes-Rastrollo, M., Martínez- González, M.A., and Serra-Majem, L. 2006. Adherence to a Mediterranean dietary pattern and weight gain in a follow-up study: the SUN cohort. Int. J. Obes. 30: 350-358.
120. Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O'Reilly, D.S., Haffner, S.M., et al. 2003. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation, 108: 414-419. doi:10.1161/01.CIR.0000080897.52664.94.
121. Scherer, P.E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H.F. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270: 26746-26749.
122. Schröder, H., Marrugat, J., Vila, J., Covas, M.I., and Elosua, R. 2004. Adherence to the traditional Mediterranean diet is inversely associated with body mass index and obesity in a Spanish population. J. Nutr. 134: 3355-3361.
123. Schulze, M.B., Fung, T.T., Manson, J.E., Willett, W.C., and Hu, F.B. 2006. Dietary patterns and changes in body weight in women. Obesity (Silver Spring), 14: 1444-1453.
124. Seshadri, P., Iqbal, N., Stern, L., Williams, M., Chicano, K.L., Daily, D.A., et al. 2004. A randomized study comparing the effects of a low-carbohydrate diet and a conventional diet on lipoprotein subfractions and C-reactive protein levels in patients with severe obesity. Am. J. Med. 117: 398-405. doi:10.1016/j.amjmed.2004.04.009.
125. Shubair, M.M., McColl, R.S., and Hanning, R.M. 2005. Mediterranean dietary components and body mass index in adults: the Peel Nutrition and Heart Health Survey. Chronic Dis. Can. 26: 43-51.
126. Simopoulos, A.P. 2003. Essential fatty acids in health and chronic diseases. Forum Nutr. 56: 67-70.
127. Sinha, S., Perdomo, G., Brown, N.F., and O'Doherty, R.M. 2004. Fatty acid-induced insulin resistance in L6 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J. Biol. Chem. 279: 41294-41301. doi:10.1074/jbc.M406514200.
128. Sirtori, C.R., Gatti, E., Tremoli, E., Galli, C., Gianfranceschi, G., Franceschini, G., et al. 1992. Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia. Am. J. Clin. Nutr. 56: 113-122.
129. Stewart, K.J., Bacher, A.C., Turner, K., Lim, J.G., Hees, P.S., Shapiro, E.P., et al. 2005. Exercise and risk factors associated with metabolic syndrome in older adults. Am. J. Prev. Med. 28: 9-18. doi:10.1016/j.amepre.2004. 09.006.
130. Summers, L.K., Fielding, B.A., Bradshaw, H.A., Ilic, V., Beysen, C., Clark, M.L., et al. 2002. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia, 45: 369-377. doi:10.1007/s00125-001-0768-3.
131. Tinker, L.F., Parks, E.J., Behr, S.R., Schneeman, B.O., and Davis, P.A. 1999. (n-3) Fatty acid supplementation in moderately hypertriglyceridemic adults changes postprandial lipid and apolipoprotein B responses to a standardized test meal. J. Nutr. 129: 1126-1134.
132. Tremblay, A.J., Depres, J.P., Piche, M.-E., Nadeau, A., Bergeron, J., Almeras, N., et al. 2004. Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation and components of the insulin resistance syndrome. Metabolism, 53: 310-317. doi:10.1016/j.metabol. 2003.10.011.
133. Vega-Lopez, S., Kaul, N., Devaraj, S., Cai, R.Y., German, B., and Jialal, I. 2004. Supplementation with omega3 polyunsaturated fatty acids and all-rac α-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism, 53: 236-240. doi:10.1016/j.metabol.2003.09.012.
134. Vessby, B., Unsitupa, M., Hermansen, K., Riccardi, G., Rivellese, A.A., Tapsell, L.C., et al. 2001. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU Study. Diabetologia, 44: 312-319. doi:10.1007/s001250051620.
135. Vozarova, B., Weyer, C., Hanson, K., Tataranni, P.A., Bogardus, C., and Pratley, R.E. 2001. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes. Res. 9: 414-417.
136. Wang, H., Storlien, L.H., and Huang, X.-F. 2002. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. Am. J. Physiol. Endocrinol. Metab. 282: E1352-E1359.
137. Watkins, L.L., Sherwood, A., Feinglos, M., Hinderliter, A., Babyak, M., Gullette, E., et al. 2003. Effects of exercise and weight loss on cardiac risk factors associated with syndrome X. Arch. Intern. Med. 163: 1889-1895. doi:10.1001/archinte.163.16.1889.
138. Weigert, C., Brodbeck, K., Staiger, H., Kausch, C., Machicao, F., Haring, H.U., and Schleicher, E.D. 2004. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through
139. Weintraub, M.S., Zechner, R., Brown, A., Eisenberg, S., and Breslow, J.L. 1988. Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism. J. Clin. Invest. 82: 1884-1893.
140. Wing, R.R., and Phelan, S. 2005. Long-term weight loss maintenance. Am. J. Clin. Nutr. 82(Suppl. 1): 222S-225S.
141. Woodman, R.J., Mori, T.A., Burke, V., Puddey, I.B., Watts, G.F., and Beilin, L.J. 2002. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am. J. Clin. Nutr. 76: 1007-1015.
142. Zampelas, A., Panagiotakos, D.B., Pitsavos, C., Das, U.N., Chrysohoou, C., Skoumas, Y., and Stefanadis, C. 2005. Fish consumption among healthy adults is associated with decreased levels of inflammatory markers related to cardiovascular disease: the ATTICA study. J. Am. Coll. Cardiol. 46: 120-124. doi:10.1016/j.jacc.2005.03.048.
143. Zhao, G., Etherton, T.D., Martin, K.R., West, S.G., Gillies, P.J., and Kris-Etherton, P.M. 2004. Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr. 134: 2991-2997.